PhiloGene Inc. Announces Revolutionary Advances in the Treatment of Cancer and Macular Degeneration BIO National Venture Conference 2008
University of Bristol secures multi-million deal for natural cancer drug
see our technology and pipeline
site under construction

PhiloGene Inc. is a biopharmaceutical company focused on developing and commercializing novel protein therapeutics for unmet medical and patient needs. PhiloGene' in-depth knowledge of protein therapeutics has resulted in a unique approaches that exploit the therapeutic potential of native growth and differentiation factors. As a company, we are committed to improving the quality of life of patients.

See BIO National Venture Conference 2008 presentation